Sio Capital Management, LLC Harrow Health, Inc. Transaction History

Sio Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.68 - $11.07 $1.4 Million - $2.32 Million	-209,623 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.76 - $6.93 $138,040 - $200,970	-29,000 Reduced 12.15%	209,623 $1.44 Million
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $263,591 - $472,419	-73,017 Reduced 23.43%	238,623 $1.24 Million
Q1 2020 May 15, 2020	SELL	$3.5 - $7.31 $116,550 - $243,423	-33,300 Reduced 9.65%	311,640 $1.19 Million
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $29,099 - $49,848	6,326 Added 1.87%	344,940 $2.68 Million
Q3 2019 Nov 14, 2019	SELL	$4.89 - $8.0 $647,925 - $1.06 Million	-132,500 Reduced 28.12%	338,614 $1.9 Million
Q2 2019 Aug 14, 2019	SELL	$4.2 - $8.7 $294,000 - $609,000	-70,000 Reduced 12.94%	471,114 $4.1 Million
Q1 2019 May 15, 2019	BUY	$4.75 - $7.1 $977,312 - $1.46 Million	205,750 Added 61.35%	541,114 $2.7 Million
Q4 2018 Feb 14, 2019	BUY	$2.25 - $6.11 $754,569 - $2.05 Million	335,364 New	335,364 $1.91 Million

185

21.1M

679K

1.27M

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $711M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.